Delivery Order SPE2DB22D3301-SPE2DB25FX7XJ
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a firm fixed-price pricing type, valued at $54,405.01, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of 4566173175 IPOL VIAL 5ML medical products, with an ultimate completion date of October 23, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,280.82 firm fixed price delivery order is for the supply of 4565736275 ! IPOL VIAL 5ML medical products. This award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
This federal contract award, valued at $1,280.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for a variety of medical products, including IPOL VIAL 5ML. The award does not have a set-aside designation, indicating open competition.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,561.52 Firm Fixed Price Delivery Order is for the supply of IPOL VIAL 5ML medical products.
Amerisourcebergen has a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award, valued at $16,010.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564856969 IPOL VIAL 5ML, a pharmaceutical product, with a completion date of June 11, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,426.13 firm fixed-price delivery order is for the provision of IPOL VIAL 5ML medical products, with a performance period through December 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense (DoD) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,134.70 fixed-price delivery order is for the supply of 4,564,359,523 units of IPOL VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2024.
Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA)...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,163.64 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML pharmaceutical products.
Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award, with an ID of SPE2DX15D3402|SPE2DX25F1KEZ, is a delivery order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,102.95 firm fixed-price contract is for the delivery of 4566760278 IPOL VIAL 5ML medical supplies, with a completion date of December 19, 2024.
Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,347.00 firm-fixed-price delivery order is for the provision of 4566317976 IPOL VIAL 5ML medical products. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...